The Patent Finder

Annji Pharmaceutical Co., Ltd.

Also on record
Records under this name other than the patents Annji Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Showing 1 to 3 of 3 · Back to Annji Pharmaceutical Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,969,361Cyclopropanecarboxylate esters of purine analogues
Lapsed on the fee record
Ended Mar 3, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 3, 2023USPTO record
US 8,946,282Indolin-2-one derivatives as protein kinase inhibitors
Lapsed on the fee record
Ended Feb 3, 2023 · USPTO record
Lapsed on the fee recordEnded Feb 3, 2023USPTO record
US 9,302,992Multifunctional quinoline derivatives as anti-neurodegenerative agents
Lapsed on the fee record
Ended Apr 5, 2020 · USPTO record
Lapsed on the fee recordEnded Apr 5, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited